반복영역 건너뛰기 주메뉴 바로가기 본문 바로가기

모바일메뉴 영역

CONFERENCE 2

CONFERENCE 02 Conference on AI Driven Drug Discovery & Development in Advanced Bio Initiatives

2024. 11. 05(Tue) 13:30 ~ 18:00

Time Speaker Affiliation Position Title Material Video
13:30-13:35
(5')
Pan-Sik Hwang Office of R&D Policy, Ministry of Science & ICT Deputy Minister Welcome Address
13:35-14:00
(25')
Hyouk-Mo Nam Advanced Biotechnology Division, Office of R&D Policy, Ministry of Science & ICT Chief Progress on Korea’s Advanced Bio Initiatives Nondisclosure Nondisclosure
14:00-14:30
(30')
Junhee Pyo Convergence AI Institute for Drug Discovery(CAIID), Korea Pharmaceutical and Bio-Pharma Manufacturers Association Vice Chief Introduction to AI driven drug discovery use case and K-Melloddy (Machine Learning Ledger Orchestration For Drug Discovery)
14:30-15:00
(30')
Kyong-Cheol Ko Korea Preclinical Evaluation Center, Korea Research Institute of Bioscience and Biotechnology Director Advanced Bio-Converged Digital Preclinical Strategies for Next Pandemic Preparedness
15:00-15:30
(30')
Kiwon Lee Spidercore CEO Using AI to Develop Gene Therapy Drug Candidates
15:40-16:10
(30')
Alan Aspuru-Guzik University of Toronto Professor AI for drug design and delivery: the time is now!
16:10-16:40
(30)
Hankil Son Korea Investment Partners Investment Director Domestic and International AI Drug Discovery Market Forecast and Investment Trends
16:40-17:10
(30')
Sung Jae Choi Sejong University Professor Legal Issues on the AI Machine Learning Data in The Area of the Medical Purposes
17:15-18:00
(45')
Shinyoung Lim
(Moderator)
KAIST Global Commercialization Center Hankil Son, Investment Director Principal Researcher Panel DiscussionAssisting R&D Collaboration and Global Commercialization in Advanced AI Driven Drug Discovery and Development
Hankil Son Korea Investment Partners Investment Director
Kiwon Lee Spidercore CEO
Sung Jae Choi Sejong University Professor
Junhee Pyo Convergence AI Institute for Drug Discovery(CAIID), Korea Pharmaceutical and Bio-Pharma Manufacturers Association Vice Chief
Yongjun Hwang Office of R&D Policy, Advanced Biotechnology Division, Ministry of Science & ICT Deputy Director